ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.96−0.03 (-3.03%)
Close on Nov 12, 2026Market cap $25.59MP/E –Yield –
ABVC BioPharma cash
Cash and short-term investments held at the end of each period.
ABVC BioPharma's cash was $66.45K at Sep 30, 2026. For fiscal 2025 it was $745.83K, down 19.7% from the year before. Over ten years it grew 103.3% a year on average. The highest annual figure on record is $6.67M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $745.83K | -19.7% |
| FY2024 | Dec 31, 2024 | $928.55K | +16.6% |
| FY2023 | Dec 31, 2023 | $796.09K | -45.8% |
| FY2022 | Dec 31, 2022 | $1.47M | -78.0% |
| FY2021 | Dec 31, 2021 | $6.67M | +33.4% |
| FY2020 | Dec 31, 2020 | $5.00M | +3017.2% |
| FY2019 | Dec 31, 2019 | $160.44K | -21.7% |
| FY2017 | Sep 30, 2017 | $204.85K | +18.0% |
| FY2016 | Sep 30, 2016 | $173.54K | -82.6% |
| FY2015 | Sep 30, 2015 | $994.83K | +160875.7% |
| FY2013 | Sep 30, 2013 | $618 | -95.4% |
| FY2012 | Sep 30, 2012 | $13.39K | -81.4% |
| FY2011 | Sep 30, 2011 | $71.78K | +2451.0% |
| FY2010 | Sep 30, 2010 | $2.81K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $66.45K | -74.2% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $94.36K | -91.7% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $202.51K | -75.4% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $745.83K | -19.7% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $257.24K | -69.4% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $1.14M | +39.5% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $824.62K | +12.2% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $928.55K | +16.6% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $840.68K | -29.3% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $818.45K | -0.1% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $734.92K | -60.7% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $796.09K | -45.8% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $1.19M | -41.9% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $818.98K | -77.8% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $1.87M | -47.0% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $1.47M | -78.0% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $2.05M | -55.1% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $3.68M | +122.2% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $3.53M | +5.8% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $6.67M | +33.4% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $4.56M | +2903.6% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $1.66M | +307.8% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $3.33M | +2284.4% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $5.00M | +3017.2% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $151.85K | -85.6% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $406.37K | -27.0% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $139.79K | -86.0% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $160.44K | -21.7% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $1.05M | +12961.0% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $556.43K | +422.9% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $997.43K | +5249.6% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $204.85K | +18.0% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $8.05K | -90.5% |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $106.41K | -87.8% |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $18.65K | -95.6% |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $173.54K | -82.6% |
| Q3 FY2016CQ2 2016 | Jun 30, 2016 | $84.90K | – |
| Q2 FY2016CQ1 2016 | Mar 31, 2016 | $872.64K | – |
| Q1 FY2016CQ4 2015 | Dec 31, 2015 | $423.97K | – |
| Q4 FY2015CQ3 2015 | Sep 30, 2015 | $994.83K | – |
See a number that looks wrong?